Quantcast

Latest Hydrazines Stories

2014-08-04 08:27:58

REHOVOT, Israel, August 4, 2014 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ] Ltd. today announced that the European Medicines Agency (EMA) has deemed ND0612H, its product candidate offering continuous delivery of levodopa/carbidopa (LD/CD) treatment for advanced Parkinson's disease, eligible for a European Union marketing authorization application procedure ("centralized procedure"). According to EMA guidelines, the EMA can allow products for which the centralized...

2013-09-17 23:02:46

MarketPublishers.com announces that a new research study on the monomethylhydrazine (CAS 60-34-4) market created by BAC Reports is available in its catalogue. London, UK (PRWEB) September 17, 2013 MarketPublishers.com announces that a new research study on the monomethylhydrazine (CAS 60-34-4) market created by BAC Reports is available in its catalogue. The newly published report “Monomethylhydrazine (CAS 60-34-4) Market Research Report 2013” offers in-depth insights into the...

2012-06-21 23:02:01

A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson´s disease (PD) regimen, significantly improved the duration of the drugs´ effectiveness in people with advanced PD, according to research led by Dr. C. Warren Olanow at Mount Sinai School of Medicine. New York, NY (PRWEB) June 21, 2012 A new delivery method for levodopa/carbidopa, a common dual-drug Parkinson´s disease (PD) regimen, significantly improved the duration of the drugs´ effectiveness...

2012-04-18 10:48:00

A levodopa-carbidopa intestinal gel (LCIG) works better than standard oral levodopa-carbidopa in reducing "off" time in patients with advanced Parkinson's disease. That's according to results of the phase three randomized, double-blind clinical trial of LCIG, to be presented as part of the Emerging Science program (formerly known as Late-Breaking Science) at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012. "Off" time occurs when Parkinson's...

2010-05-12 07:00:00

WALTHAM, Mass., May 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while levodopa remains the gold standard for Parkinson's disease treatment, physicians say they will increasingly use other agents to delay the need for levodopa. According to the new report entitled Treatment Algorithms in Parkinson's Disease, 46 percent of surveyed neurologists say it is "very likely" or "likely" they will...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'